Alpha-1 Global mourns the loss of Guillermo Menga, MD
It is with a heavy heart that the Alpha-1 Global program, at the Alpha-1 Foundation, announces the passing of Guillermo Menga, MD, director of the Municipal Hospital for Respiratory Rehabilitation, María Ferrer, in Buenos Aires, Argentina, on Saturday, June 29, 2019. He was 61.
Menga led the Argentine Association of Respiratory Medicine and his tenure is remembered as a milestone in public health in Argentina, with a focus on promoting health in order to fight and prevent pulmonary diseases in the South American country.
“The community of our specialty, in Argentina and Latin America, is mourning because it has lost a champion in his most productive and expert hours,” said Gustavo Zabert, president of the Asociación Latinoamericana del Tórax (Latin American Thoracic Society, ALAT).
Menga suffered from an autoimmune disease, but that never stopped him from his duties and responsibilities and from being there for his patients. However, it ultimately won the battle against him.
Besides leading the Argentine Association of Respiratory Medicine, Menga was the coordinator of the Programa Nacional de Asistencia al Paciente Miasténico (National Program of Assistance to the Myasthenic Patient), since 2004, and the coordinator of the Registro Argentino de Pacientes con Déficit de Alfa-1 Antitripsina (Alpha-1 Antitrypsin Deficiency Patient Registry of Argentina), under the Alpha One International Registry (AIR), in Argentina, since 2003.
Menga attended the Alpha-1 Global International Research Conference on Alpha-1 Antitryspin and Alpha-1 Global Patient Congress on 2015, 2017, and 2019. He gave more than 50 specialized courses and seminars and published 60 scientific works that contributed to the treatment of several diseases, and also received many awards and recognitions for this work.
But beyond his work and valuable contributions to international medicine, people will remember Menga as a role model and a physician who always put patients first.
Source: Clarín (Argentina)